Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

EU takes legal steps against AZ over delayed COVID-19 vaccine deliveries

Lawyers for the European Commission have asked the court to fine AZ €10m per infraction

- PMLiVE

Health Unlimited to acquire medcomms consultancy Strategen

Health Unlimited said the acquisition of Strategen will further strengthen its medical education services

- PMLiVE

Nicky Hutchens appointed as deputy managing director at Four Health

Hutchens initially joined Four Health in 2017 as an account director

- PMLiVE

Rare diseases: why they can be so difficult to identify

Symptoms shared with more common diagnoses can make it more difficult to spot underlying rare diseases

- PMLiVE

FDA priority review granted for J&J, Legend Biotech’s myeloma CAR T therapy

CAR T therapy demonstrated an overall response rate of 97% in relapsed/refractory multiple myeloma patients after 12.4 months

- PMLiVE

Sanofi, GSK begin enrolment for phase 3 COVID-19 vaccine study

Study will investigate two formulations targeting the Wuhan strain and the South African variant

- PMLiVE

Novartis, Molecular Partners launch global study of novel COVID-19 drug

Initial positive phase 1 study results found that the drug was safe and well tolerated, with no significant adverse events reported

- PMLiVE

Wilmington Healthcare hires Kirsty Fryer as solutions director

Fryer has worked at Wilmington Healthcare since 2015, serving as a solutions consultant at the company since November 2017

Lucid Group make the cut for Communiqué in seven different categories.

Lucid Group’s pioneering approach to healthcare communications has been recognised with five of its programmes making the shortlist across five categories, as well as making the finals for the two company awards:The five shortlisted programme category awards are:EXCELLENCE IN NATIONAL OR LOCAL EDUCATION MEETINGS/STAND-ALONE...

Lucid Group Communications Limited

- PMLiVE

Wilmington Healthcare appoints new Solutions Director

Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare

Wilmington Healthcare

Roche Basel Switzerland

EC approves Venclyxto-based combinations for newly diagnosed AML

The treatment is approved for newly diagnosed acute myeloid leukaemia patients who can’t receive intensive chemotherapy

- PMLiVE

Launch excellence in COVID-19 times

By Stephanie Hall

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links